The COVID-19 products from Beijing Wantai Biological Pharmacy

Our supplier and partner Beijing Wantai Biological Pharmacy has developed diverse serology and molecular kits for screening and confirmation of COVID-19. In the field of human infectious diseases and blood donor screening, Beijing Wantai Biological is China’s largest supplier for diagnostic in vitro tests and reagents. Wantai focusses on the diagnosis of eight human infectious diseases. Wantai is well known for their excellent Hepatitis E Diagnostic Tests. Several KOL's in the BeNeLux are using Wantai products in their procedures.

COVID-19 products of Wantai

Along with the spreading global pandemic of Novel Coronavirus, countries around the world have been struggling to diagnose and control this disease in time. Xiamen University and Wantai have jointly developed a series of innovative, highly sensitive and specific serological and molecular assays for testing of Covid-19. Time to results is critical and labs around the world are under a lot of pressure to provide test results fast. Wantai can offer complete coronavirus diagnostic markers profile in just 75min.

The following Wantai kits are available:

Itemnumber	Description	Size	Price
WS-1196	SARS-CoV-2 IgM ELISA (CE-IVD), on stock	96 T	Price on request
WS-1096	SARS-CoV-2 Ab ELISA (CE-IVD), on stock	96 T	Price on request
WJ-2750	Rapid test for Corona virus Ab (CE-IVD), on stock	50 T	Price on request
WJ-2810	Rapid test for Corona virus IgM	10 T	Price on request
WJ-2850	Rapid test for Corona virus IgM	50 T	Price on request
WS-1248	Nucleic Acid Detection Kit 2019-nCoV (CE-IVD)	48 T	Price on request

One million Wantai tests bought by the Netherlands

Minister Hugo de Jonge of Health, Welfare and Sport (VWS) and special coronavirus envoy Mr. Feike Sijbesma presented the test kits on May 5^th to Prof. Dr. Rene van Lier, Vice Chairman of the Executive Board and Research Director of Sanquin blood bank. The Ministry of Health has ordered the Wantai SARS-CoV-2 Ab ELISA tests together with blood bank Sanquin as the test makes it possible to gain insight into how the virus is spreading in the Netherlands.

SARS-CoV-2 Ab ELISA

Background information

Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by infection with the SARS-CoV-2 virus. Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In severe cases, infection can cause pneumonia, severe acute respiratory syndrome (SARS), kidney failure and death. Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). The 2019 novel coronavirus, formerly known as 2019-nCoV and now known as SARS-CoV-2, is a new strain of coronavirus that was first identified during an outbreak in Wuhan, China which started in December 2019.